| Elevated blood cyanide concentrations in victims of smoke inhalation FJ Baud, P Barriot, V Toffis, B Riou, E Vicaut, Y Lecarpentier, R Bourdon, ... New England Journal of Medicine 325 (25), 1761-1766, 1991 | 564 | 1991 |
| Review of therapeutic drug monitoring of anticancer drugs part two–targeted therapies N Widmer, C Bardin, E Chatelut, A Paci, J Beijnen, D Levêque, G Veal, ... European journal of cancer 50 (12), 2020-2036, 2014 | 339 | 2014 |
| Lipid‐lowering drugs and mitochondrial function: effects of HMG‐CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio G De Pinieux, P Chariot, M AMMI‐SAÏD, F Louarn, JL Lejonc, A Astier, ... British journal of clinical pharmacology 42 (3), 333-337, 1996 | 337 | 1996 |
| Physicochemical stability of monoclonal antibodies: a review Y Le Basle, P Chennell, N Tokhadze, A Astier, V Sautou Journal of Pharmaceutical Sciences 109 (1), 169-190, 2020 | 297 | 2020 |
| Review of therapeutic drug monitoring of anticancer drugs part 1–cytotoxics A Paci, G Veal, C Bardin, D Levêque, N Widmer, J Beijnen, A Astier, ... European journal of cancer 50 (12), 2010-2019, 2014 | 281 | 2014 |
| The preparation and evaluation of poly (ϵ-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug MH Perez, C Zinutti, A Lamprecht, N Ubrich, A Astier, M Hoffman, ... Journal of controlled release 65 (3), 429-438, 2000 | 253 | 2000 |
| Guidelines for the practical stability studies of anticancer drugs: a European consensus conference C Bardin, A Astier, A Vulto, G Sewell, J Vigneron, R Trittler, M Daouphars, ... Annales pharmaceutiques francaises 69 (4), 221-231, 2011 | 198 | 2011 |
| Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole FJ Baud, M Galliot, A Astier, DV Bien, R Garnier, J Likforman, C Bismuth New England Journal of Medicine 319 (2), 97-100, 1988 | 192 | 1988 |
| Therapeutic drug monitoring in cancer–are we missing a trick? C Bardin, G Veal, A Paci, E Chatelut, A Astier, D Levêque, N Widmer, ... European journal of cancer 50 (12), 2005-2009, 2014 | 134 | 2014 |
| 4-Methylpyrazole may be an alternative to ethanol therapy for ethylene glycol intoxication in man FJ Baud, C Bismuth, R Garnier, M Galliot, A Astier, G Maistre, M Soffer Journal of Toxicology: Clinical Toxicology 24 (6), 463-483, 1986 | 118 | 1986 |
| Reemergence of Gentamicin-Susceptible Strains of Methicillin-Resistant Staphylococcus aureus: Roles of an Infection Control Program and Changes in … H Aubry-Damon, P Legrand, C Brun-Buisson, A Astier, CJ Soussy, ... Clinical infectious diseases 25 (3), 647-653, 1997 | 104 | 1997 |
| Induction of inosine monophosphate dehydrogenase activity after long‐term treatment with mycophenolate mofetil S Sanquer, M Breil, C Baron, D Dhamane, A Astier, P Lang Clinical Pharmacology & Therapeutics 65 (6), 640-648, 1999 | 103 | 1999 |
| Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics E Cauchetier, M Deniau, H Fessi, A Astier, M Paul International journal of pharmaceutics 250 (1), 273-281, 2003 | 97 | 2003 |
| Long-term stability of diluted solutions of the monoclonal antibody rituximab M Paul, V Vieillard, E Jaccoulet, A Astier International journal of pharmaceutics 436 (1-2), 282-290, 2012 | 88 | 2012 |
| Melarsoprol–cyclodextrins inclusion complexes S Gibaud, SB Zirar, P Mutzenhardt, I Fries, A Astier International journal of pharmaceutics 306 (1-2), 107-121, 2005 | 84 | 2005 |
| Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells A Astier, B Doat, MJ Ferrer, G Benoit, J Fleury, A Rolland, R Leverge Cancer research 48 (7), 1835-1841, 1988 | 83 | 1988 |
| Mechanically-induced aggregation of the monoclonal antibody cetuximab A Lahlou, B Blanchet, M Carvalho, M Paul, A Astier Annales pharmaceutiques francaises 67 (5), 340-352, 2009 | 72 | 2009 |
| Inhibition of hydroxyl radical production by lactobionate, adenine, and tempol C Charloux, M Paul, D Loisance, A Astier Free Radical Biology and Medicine 19 (5), 699-704, 1995 | 72 | 1995 |
| Comparison of nanosuspensions and hydroxypropyl-β-cyclodextrin complex of melarsoprol: Pharmacokinetics and tissue distribution in mice SB Zirar, A Astier, M Muchow, S Gibaud European journal of pharmaceutics and biopharmaceutics 70 (2), 649-656, 2008 | 67 | 2008 |
| Relation between plasma lactate and blood cyanide concentrations in acute cyanide poisoning FJ Baud, SW Borron, E Bavoux, A Astier, JR Hoffman Bmj 312 (7022), 26-27, 1996 | 67 | 1996 |
